Analysis

  • New Breakthroughs? You Can Biobank On It

    Paul French gets an update on where the EU's Biomolecular Resources Research Infrastructure is headed. He speaks to BBMRI coordinator Kurt Zatloukal, 18 months out from operation.

  • Combating the Counterfeit Culture

    The global counterfeit medicines market is threatening public health and the reputation of the legitimate pharmaceutical industry. Chris Lo finds out the extent of the problem and how the industry...

  • No Cure for Drug Labelling Mistakes

    New standards for drug labels are due to come into force in early 2011. Because of this, Steve Rogerson reports, packaging companies have to pay extra attention to how they...

  • The Race for a Malaria Vaccine

    Malaria is one of the most serious infectious diseases in the world. Accordingly, there is little surprise that major research is being undertaken to find a cure. Kenya McCullum caught...

  • Managing People, Managing Data

    More and more pharmaceutical and biotechnology companies are moving towards a fully integrated lab. We take a look at a Swiss case study ahead of Arena International's Laboratory Data Management...

  • The Problems and Promises of Stem Cell Research

    The stem cell industry is making heady progress in the US, with new legislation on embryonic stem cell research, new National Institute of Health approvals and the first FDA-approved clinical...

Close
Close
Close

Go Top